Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2025)

Rapid Micro Biosystems' Income from Continuing Operations history spans 6 years, with the latest figure at 12497000.0 for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations fell 29.29% to 12497000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 47123000.0, a 0.5% change, with the full-year FY2025 number at 47123000.0, changed 0.5% from a year prior.
  • Income from Continuing Operations hit 12497000.0 in Q4 2025 for Rapid Micro Biosystems, down from 11505000.0 in the prior quarter.
  • Over the last five years, Income from Continuing Operations for RPID hit a ceiling of 9666000.0 in Q4 2024 and a floor of 24987000.0 in Q3 2021.
  • Historically, Income from Continuing Operations has averaged 14041950.0 across 5 years, with a median of 13212500.0 in 2022.
  • Biggest five-year swings in Income from Continuing Operations: tumbled 195.18% in 2021 and later soared 34.61% in 2022.
  • Tracing RPID's Income from Continuing Operations over 5 years: stood at 14605000.0 in 2021, then decreased by 12.73% to 16464000.0 in 2022, then soared by 32.14% to 11172000.0 in 2023, then increased by 13.48% to 9666000.0 in 2024, then decreased by 29.29% to 12497000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for RPID at 12497000.0 in Q4 2025, 11505000.0 in Q3 2025, and 11858000.0 in Q2 2025.